Error: Could not add to watchlist. X
+ Watchlist

Synageva BioPharma Corp

GEVA:US
Acquired
GEVA:US was acquired by ALXN:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-6.34
Market Cap (USD)
-
Shares Outstanding (m)
37.163
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.45%
% Price Change
+0.41%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
Address
128 Spring Street
Suite 520
Lexington, MA 02421
United States
Phone
1-781-357-9900
Show More